文献速递运动医学关节外科

同种异体骨与自体骨在距骨骨软骨损伤骨软骨移植中的比较

Allograft Compared with Autograft in Osteochondral Transplantation for the Treatment of Osteochondral Lesions of the Talus.
PubMed 文献 · J Bone Joint Surg Am · 2018-01-01

本研究回顾性比较了自体骨与同种异体骨移植治疗距骨骨软骨损伤的临床和影像学结果。纳入25例自体骨和16例异体骨患者,随访分别平均26个月和22个月。自体骨组术后FAOS、SF-12和MOCART评分均显著优于异体骨组,异体骨组软骨磨损率、移植物内囊肿形成率和二次手术率更高。

要点

  • 自体骨组术后FAOS平均81.9,异体骨组70.1,差异有统计学意义(p=0.006)。
  • 异体骨组MRI软骨磨损率53%,高于自体骨组的4%(p<0.001)。
  • 异体骨组移植物内囊肿形成率47%,高于自体骨组的8%(p=0.017)。

核心结论

  • 在这项小型非随机队列研究中,使用自体骨的手术提供了比同种异体骨手术更好的临床和MRI结果。
  • 同种异体骨治疗的软骨磨损率高于自体骨,且同种异体骨治疗的患者临床失败率更高。

研究设计与样本

  • 回顾性分析比较接受自体骨或同种异体骨移植治疗距骨骨软骨损伤的患者。
  • 纳入25例非随机自体骨患者和16例异体骨患者,自体骨组平均随访26个月,异体骨组平均随访22个月。
  • 临床结果采用足踝结果评分(FAOS)和简表-12(SF-12)评估,MRI采用软骨修复组织磁共振观察(MOCART)评分评估。
  • 评估囊肿发生、移植物退化、移植物失败和翻修手术率。

主要发现

  • 自体骨组术后FAOS平均81.9(95%CI 78.6至85.2),异体骨组70.1(95%CI 63.7至76.5),p=0.006。
  • 自体骨组术后SF-12平均74.7(95%CI 71.0至78.4),异体骨组66.1(95%CI 61.2至71.0),p=0.021。
  • 自体骨组MOCART评分87.1,异体骨组75.5,p=0.005。
  • MRI软骨磨损率异体骨组53%,自体骨组4%,p<0.001。
  • 移植物内囊肿形成率异体骨组47%,自体骨组8%,p=0.017;移植物二次手术率异体骨组25%,自体骨组0%,p=0.009。

关键数值与推荐

  • 术后FAOS自体骨组81.9(95%CI 78.6至85.2)vs 异体骨组70.1(95%CI 63.7至76.5),p=0.006。
  • 术后SF-12自体骨组74.7(95%CI 71.0至78.4)vs 异体骨组66.1(95%CI 61.2至71.0),p=0.021。
  • MOCART评分自体骨组87.1 vs 异体骨组75.5,p=0.005。
  • MRI软骨磨损率异体骨组53% vs 自体骨组4%,p<0.001。
  • 移植物内囊肿形成率异体骨组47% vs 自体骨组8%,p=0.017;移植物二次手术率异体骨组25% vs 自体骨组0%,p=0.009。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 这是一项小型非随机队列研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a paucity of clinical studies that compare the efficacy of autograft and allograft in osteochondral transplantation for treatment of osteochondral lesions of the talus (OLT). The purpose of the present study was to compare the clinical and radiographic outcomes following osteochondral transplantation with autograft or allograft for OLT. METHODS: A retrospective analysis comparing patients treated with autograft or allograft for OLT was performed. Clinical outcomes were evaluated with use of the Foot and Ankle Outcome Score (FAOS) and the Short Form-12 (SF-12) score. Magnetic resonance imaging (MRI) was evaluated with use of the Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) score. The rates of cyst occurrence, graft degradation, graft failure, and revision surgeries were also evaluated. RESULTS: Twenty-five nonrandomized patients with autograft and 16 with allograft were included, with a mean follow-up of 26 months in the autograft group and 22 months in the allograft group. There were no significant differences among all demographic variables between the autograft and allograft groups. The mean postoperative FAOS was significantly higher in the autograft group (81.9; 95% confidence interval [CI]: 78.6 to 85.2) than in the allograft group (70.1; 95% CI: 63.7 to 76.5; p = 0.006). Similarly, the mean postoperative SF-12 scores were significantly higher in the autograft group (74.7; 95% CI: 71.0 to 78.4) than in the allograft group (66.1; 95% CI: 61.2 to 71.0; p = 0.021). MOCART scores were significantly better in the autograft group (87.1) than in the allograft group (75.5; p = 0.005). The rate of chondral wear on MRI was higher in the allograft group (53%) than in the autograft group (4%; p < 0.001). Cyst formation in the graft itself was more likely to occur in the allograft group (47%) than in the autograft group (8%; p = 0.017). The rate of secondary procedures for the graft was higher in the allograft group (25%) than in the autograft group (0%; p = 0.009). CONCLUSIONS: In this small nonrandomized cohort study, the procedures performed with use of an autograft provided better clinical and MRI outcomes than the allograft procedures. The rate of chondral wear on MRI was higher with allograft than with autograft, and allograft-treated patients had a higher rate of clinical failure. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Shimozono Y, Hurley ET, Nguyen JT, et al. Allograft Compared with Autograft in Osteochondral Transplantation for the Treatment of Osteochondral Lesions of the Talus. J Bone Joint Surg Am. 2018. PMID: 30399078. doi:10.2106/JBJS.17.01508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。